Global Prostate Cancer Therapeutics Market to 2020

About This Presentation
Title:

Global Prostate Cancer Therapeutics Market to 2020

Description:

Renub Research has announced the addition of the "" report to its offering – PowerPoint PPT presentation

Number of Views:55

less

Transcript and Presenter's Notes

Title: Global Prostate Cancer Therapeutics Market to 2020


1
Global Prostate Cancer Therapeutics Market to 2020
Renub Research www.renub.com
Published November, 2015 Copyright 2015
Renub Research All Rights Reserved
2
Table of Content
1. Executive Summary 2. Prostate Cancer
Overview 2.1 Prostate Cancer Introduction 2.2 Risk
Factors 2.2.1 Age 2.2.2 Race 2.2.3 Family
History/Genetics 2.2.4 Diet/Lifestyle Factors

3
Continue (www.renub.com)
2.2.5 Obesity 2.2.6 Infection/Inflammati
on of the Prostate Gland 2.3 Disease
Symptoms 2.4 Diagnosis 2.4.1 Digital
Rectal Exam (DRE) 2.4.2 Prostate Specific
Antigen (PSA) Blood Test 2.4.3 Prostate
Ultrasound and Biopsy 2.4.4 Bone Scan

4
Continue (www.renub.com)

2.4.5 CT Scan MRI 2.4.6 PET
SPECT Scan 2.4.7 Lymph Node Biopsy 2.4.8
ProstaScint Scan 2.5 Stages of Prostate
Cancer 2.5.1 Stage I 2.5.2 Stage
II 2.5.3 Stage III 2.5.4 Stage IV
 
5
Continue (www.renub.com)
 
3. Global Prostate Cancer Drugs Market 4. Global
Prostate Cancer Incidence 5. Global Prostate
Cancer Drugs Market Share 6. Global Prostate
Cancer Hormonal Therapy Drugs Sales Forecast
to 2020 6.1 Luteinizing Hormone Releasing
Hormone (LHRH) Antagonists 6.1.1 Zytiga
 

6
Continue (www.renub.com)
6.1.2 Gonax / Firmagon 6.2 Luteinizing
Hormone Releasing Hormone (LHRH)
Analogs 6.2.1 Lupron 6.2.2 Zoladex 6.2.3
Decapeptyl 6.2.4 Eligard 6.2.5
Vantas 6.2.6 Leuplin
7
Continue (www.renub.com)
6.3 Anti Androgens 6.3.1 Casodex 6.3.2 Xtandi
or MDV3100 6.3.3 Xtandi US or MDV3100 7. Global
Prostate Cancer Chemotherapy Drugs
Market 7.1 Taxotere 7.2 Jevtana 8. Global
Prostate Cancer Immunotherapy Drugs
Market 8.1 Provenge
8
Continue (www.renub.com)
  • Global Prostate Cancer Targeted Therapy
  • Drugs Market
  • 9.1 Xofigo or Alpharadin
  • 10. Global Prostate Cancer Market Driving
  • Factors
  • 10.1 Introduction of Innovative Drugs
  • 10.2 Advancement in Oncology Therapeutic Area
  • 10.3 Development in Genomics Proteomics

9
Continue (www.renub.com)
11. Global Prostate Cancer Market
Challenges 11.1 Costly Prostate Cancer
Drugs 11.2 Adverse Events of Treatment 11.3 Low
Success Rate for Oncology Drugs
10
Order Form
Scan and e-mail this page to info_at_renub.com,
alternatively one can also write the Contact
Information in an e-mail and mail it. Else you
can also fax this form to 91-120-424-9780
Questions? Please call
1-678-302-0700 (USA)
91-120-421-9822 (India), ,91-120-424-9780
or mail to info_at_renub.com
11
Format
Report Title Global Prostate Cancer Therapeutics
Market to 2020
For More Details
http//www.renub.com/global-prostate-cancer-therap
eutics-market-to-2020-487-p.php
Single User (Email from Publisher) Hard Copy (Mail Delivery) CD Rom (Mail Delivery) Global Site License (Multiple User License)
US 1,200 US 1,300 US 1,300 US 1,800
12
For ordering this report Easy ways to place
your order
  • Order online by Credit Card (Visa, MasterCard,
    etc.)
  • http//www.renub.com/global-prostate-cancer-therap
    eutics-market-to-2020-487-p.php

13
Bank Details
  • Account Name Renub Research
  • A/C No. 109102000023296
  • Name of Bank IDBI Bank Ltd.
  • Swift Code IBKLINBB010
  • Bank Address 4th Floor
  • Indian Red Cross Building
  • 1 Red Cross Road
  • Opposite Parliament Street
  • New Delhi 110001
  • India

14
Contact Information
  First Name
Last Name Email Job Title
Company Address City Postal/Zip Code
Country Phone Mobile Fax Report
Format Your message
15
Order by Check
  • Please post the check accompanied by this form,
    to
  • Company Address Renub Research
  • 1st Floor,
  • C-86, Sector-10
  • Noida - 201301
  • Uttar Pradesh
  • India
  • Phone
    91-120-421-9822, 424-9780
  • For free Sample copy report or to view any of our
    sample work please contact us at info_at_renub.com
    or call 91-120-421-9822 (India), 1-678-302-0700
    (USA)
Write a Comment
User Comments (0)